LSU looks to sell interest in biotech company


    LSU may be about to sell its stake in TransGenRx, a biopharmaceutical manufacturing company founded in 2003 that essentially uses genetically altered eggs to produce proteins for human medicines. The …

    Already an INSIDER? .

    We are glad you enjoy reading Business Report.

    Continue reading this story and get ACCESS to all our content from any device with a subscription now.

    • Get access to more than a decade of story archives.
    • Get access to our searchable data center of TOP LISTS.
    • Get exclusive content only available to INSIDERS.